ITEM ONE: To approve the individual and consolidated Annual Report, Financial Statements and other documents, including the Company’s Corporate Governance Report (which incorporates the remuneration report) and consolidated non-financial statements for the year 2021;
Annual Integrated Report - Non-ESEF Version
ITEM TWO: To approve the distribution and allocation of profits relating to the financial year of 2021;
ITEM THREE: To deliberate the increase of the Company’s total share capital by 850,016,277.00 euros by incorporating the Share Premium Reserves reflected in the Company accounts for 2021, that
remains after the allocation of net results for the year. The proposal implies a 1.65 euro increase in the nominal value of all shares to 1.66 euro and, consequently, an amendment of paragraphs (1) and (2) of Article 4 of the Company’s Articles of Association;
ITEM FOUR:To assess the Company’s management and supervisory bodies;
ITEM FIVE: To authorise the Board of Directors to acquire and dispose of own shares on behalf of the Company and its subsidiaries;
ITEM SIX: To authorise the Board of Directors to acquire and dispose of own bonds on behalf of the Company and its subsidiaries;
ITEM SEVEN: To approve the amendment to Article 10 of the Company's Articles of Association, modifying the current number 6, adding two new numbers 7 and 8 and renumbering the current number 7;
ITEM EIGHT: To elect new members for the Board of Directors, the Board of the General Meeting, and the Statutory Audit Board, for the three-year term 2022/2024.
ITEM NINE: To elect the Statutory Auditor, effective and alternate, for the 2022/2023 biennium.
ITEM TEN: To appoint the Remuneration Committee for the three-year period 2022/2024 and to approve remuneration for the members of this committee.